Big Pharma’s View of Emerging Technologies for Partnership & Investment

Merck, Lilly, Amgen and Takeda S&E, BD and venture leads talk about what it takes to get them interested in a new technology. Look at their recent deals, why they got done and challenges faced. Understand what tech/modalities and platforms are seen as compelling, and how to position your asset or platform optimally. There will be live Q&A, and a recording will be available for registrants